Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Linda Elberskirch"'
Autor:
Linda Elberskirch, Kunigunde Binder, Norbert Riefler, Adriana Sofranko, Julia Liebing, Christian Bonatto Minella, Lutz Mädler, Matthias Razum, Christoph van Thriel, Klaus Unfried, Roel P. F. Schins, Annette Kraegeloh
Publikováno v:
Particle and Fibre Toxicology, Vol 19, Iss 1, Pp 1-19 (2022)
Abstract Background Assessing the safety of engineered nanomaterials (ENMs) is an interdisciplinary and complex process producing huge amounts of information and data. To make such data and metadata reusable for researchers, manufacturers, and regula
Externí odkaz:
https://doaj.org/article/26de6d8b78c8470aaceb5e6eefe5a8a9
Autor:
Linda Elberskirch, Adriana Sofranko, Julia Liebing, Norbert Riefler, Kunigunde Binder, Christian Bonatto Minella, Matthias Razum, Lutz Mädler, Klaus Unfried, Roel P. F. Schins, Annette Kraegeloh, Christoph van Thriel
Publikováno v:
Nanomaterials, Vol 12, Iss 7, p 1053 (2022)
It has been widely recognized that nanosafety studies are limited in reproducibility, caused by missing or inadequate information and data gaps. Reliable and comprehensive studies should be performed supported by standards or guidelines, which need t
Externí odkaz:
https://doaj.org/article/8dd9b552a0d54a179664af8cfbaa422d
Autor:
Dietrich Scheglmann, Maria Mathieu-Gaedke, Hartwig R. A. Golf, Linda Elberskirch, Arno Wiehe, Hagen von Briesen, Sylvia Wagner, Ronan Le Harzic, Gerhard D. Wieland
The development of new tumor models for anticancer drug screening is a challenge for preclinical research. Conventional cell-based in vitro models such as 2D monolayer cell cultures or 3D spheroids allow an initial assessment of the efficacy of drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39187f91674a4bbd19f1f3ce56cb0e44
Autor:
Janis Renner, Thorsten Knoll, Rebecca Königsmark, Sylvia Wagner, Hagen von Briesen, Nadine Wilhelm, Linda Elberskirch
Publikováno v:
Journal of Drug Delivery Science and Technology. 63:102496
For the treatment of intestinal tumors by oral administration of drugs, the mucus layer of the intestine represents a barrier, but also a target possibility for drug. The use of nanoparticular drug delivery systems is an important tool to improve the
Autor:
Sylvia Wagner, Thorsten Knoll, Linda Elberskirch, Hagen von Briesen, Nadine Wilhelm, Aline Moosmann
A major challenge of drug discovery is to overcome the mucus barrier, which is lined the surface of the gastrointestinal tract. The ability to overcome this barrier must be tested in preclinical in vitro models, prior to in vivo studies. Therefore, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4385a52998e12091b0212e75765b1243
https://publica.fraunhofer.de/handle/publica/260805
https://publica.fraunhofer.de/handle/publica/260805